Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference27 articles.
1. Luznik L, O’Donnell P, Symons H, Chen A, Leffell M, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. BBMT. 2008;14:641–50.
2. Elmariah H, Pratz K. Role of alternative donor allogeneic transplants in the therapy of acute myeloid leukemia. JNCCN. 2017;15:959–66.
3. McCurdy S, Kanakry J, Showel M, Tsai H, Bolaños-Meade J, Rosner G, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015;125:3024–31.
4. McCurdy S, Kasamon Y, Kanakry C, Bolaños-Meade J, Tsai H, Showel M, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide. Haematologica. 2017;102:391–400.
5. Ciurea S, Zhang M, Bacigalupo A, Bashey A, Appelbaum F, Aljitawi O, et al. Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia. Blood. 2015;126:1033–40.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献